4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-001981
Director sold 280 shares at $551.24 ($154,348)
- Director acquired 280 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2026-01-09 | Option exercise 10b5-1 | +280 | $15.80 | $4,424 | 187,444 | D |
| FRIEDMAN PAUL A Director | 2026-01-09 | Sale 10b5-1 | −280 | $551.24 | $154,348 | 187,164 | D |
| Derivatives | |||||||
| FRIEDMAN PAUL A Director | 2026-01-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −280 | 0 | D | ||
| Open-market sales · 280 sh · avg $551.24 · $154,348 | |||||||
Loading xslF345X05/wk-form4_1768340834.xml…